Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids

Journal of Rheumatology

Volumn 24, Issue 10, 1997, Pages 1922-1929

  Kipen, Yael ^a   Buchbinder, Rachelle ^d   Forbes, Andrew ^b   Strauss, Boyd ^c   Littlejohn, Geoffrey ^a   Morand, Eric ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Body Composition Laboratory

^d Centre for Inflammatory Diseases ^*

Author keywords

Bone mineral density; Osteoporosis; Steroids; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CORTICOSTEROID THERAPY; DOSE TIME EFFECT RELATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 0030862794     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Black DM, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner W: Axial and appendicular bone density predict fractures in older women. J Bone Mineral Res 1992;7:633-8.
2. Ross PD, Davis JW, Vogel JM, Wasnich RD: A critical review of bone mass and the risk of fractures in osteoporosis. Calcif Tiss Int 1990;46:149-61.
3. Cummings SR, Black DM, Nevitt MC, et al: Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72-5.
4. Magaro M, Tricerri A, Piane D, et al: Generalized osteoporosis in non-steroid treated rheumatoid arthritis. Rheumatol Int 1991;11:73-6.
5. Kroger H, Honkanen R, Saarikoski S, Alhava E: Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis - a population based study. Ann Rheum Dis 1994;53:18-23.
6. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S: Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987;30:721-8.
7. Als SO, Gotfredsen A, Riis BJ, Christiansen C: Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis? Ann Rheum Dis 1985;44:406-11.
8. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P: Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
9. Laan RFJM, Buijs WCAM, Verbeek ALM, et al: Bone mineral density in patients with recent onset rheumatoid arthritis: Influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6.
10. Laan RFJM, van Riel PLCM, Van Erning LJTHO, Lemmens JAM, Ruijs SHJ, van de Putte LBA: Vertebral osteoporosis in rheumatoid arthritis patients: Effect of low dose prednisone therapy. Br J Rheumatol 1992;31:91-6.
11. Joffe I, Epstein S: Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management. Semin Arthritis Rheum 1991;20:256-72.
12. Dhillon BV, Davies MC, Hall ML, et al: Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: A preliminary study with dual energy x-ray absorptiometry. Ann Rheum Dis 1990;49:624-6.
13. Kalla AA, Fataas B, Jeqsop SJ, Bewerunge L: Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
14. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D: Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
15. Petri M: Musculoskeletal complications of systemic lupus erythematosus in the Hopkins lupus cohort: An update. Arthritis Care Res 1995;8:137-45.
16. Pons F, Peris P, Guanabens N, et al: The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
17. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Gladman D, Ginzler E, Goldsmith C, et al: Systemic Lupus International Collaborative Clinics: Development of a damage index in systemic lupus erythematosus. J Rheumatol 1992;19:1820-1.
19. Liang MH, Socher SA, Larson MG, Schur PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
20. Pincus T, Summey JA, Soraci SA, Wallston KA, Hummon NP: Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum 1983;26:1346-53.
21. Cullum ID, Ell PJ, Ryder JP: X-ray dual-photon absorptiometry: A new method for the measurement of bone density. Br J Radiol 1989;62:587-92.
22. Lilley J, Walters BG, Heath DA, Drolc Z: In vivo and in vitro precision for bone density measured by dual-energy x-ray absorption. Osteoporosis Int 1991;1:141-6.
23. Nuti R, Martini G, Righi G, Frediani G, Turchetti V: Comparison of total body measurements by dual-energy x-ray absorptiometry and dual-photon absorptiometry. J Bone Mineral Res 1991;6:681-7.
24. Kanis JA, Melton J, Christiansen C, Johnston CC, Khaltaev N: The diagnosis of osteoporosis. J Bone Mineral Res 1994;9:1137-41.
25. Draper NR, Smith H: Applied Regression Analysis, 2nd ed. New York: John Wiley and Sons, 1981.
26. Cummings S, Black D: Bone mass measurements and risk of fracture in Caucasian women: A review of findings from prospective studies. Am J Med 1995;(suppl 2A)98:24S-28S.
27. Riis BJ: The role of bone loss. Am J Med 1995;(suppl 2A)98:29S-32S.
28. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH: Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361-86.
29. Kalla AA, Meyers OL, Parkyn ND, Kotze TJ: Osteoporosis screening - radiogrammetry revisited. Br J Rheumatol 1989;28:511-7.
30. Kalla AA, Kotze TJ, Meyers OL: Metacarpal bone mass in systemic lupus erythematosus. Clin Rheumatol 1992;11:475-82.
31. Reid IR: Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989;30:83-103.
32. Michel BA, Bloch DA, Fries JF: Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991;18:804-8.
33. Reid M, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G: Corticosteroids and bone mass in asthma: Comparisons with rheumatoid arthritis and polymyalgia rheumatica. BMJ 1986;293:1463-6.
34. Adinoff AD, Hollister JR: Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
35. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR: Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991;147:117-23.
36. Al-Janadi M, Al-Balla S, Al-Dallan A, Raziuddin S: Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993;13:58-67.
37. Tanaka Y, Watanabe K, Suzuki M, et al: Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. J Clin Immunol 1989;9:415-20.
38. MacDonald BR, Gowen M: Cytokines and bone. Br J Rheumatol 1992;31:149-55.
39. Babini SM, Arturi A, Marcos JC, Babini JC, Iniguez AM, Morteo OG: Laxity and rupture of the patellar tendon in systemic lupus erythematosus. Association with secondary hyperparathyroidism. J Rheumatol 1988;15:1162-5.
40. Wallace DJ: The endocrine system and urogenital tract. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. Philadelphia: Lea and Febiger, 1993:407-9.
41. Gladman D: Prognosis of systemic lupus erythematosus and the factors that affect it. Curr Opin Rheumatol 1991;3:789-96.
42. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL: Systemic lupus erythematosus - survival patterns. JAMA 1981;245:934-8.
43. Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer J-P, Nagant de Deuxchaisnes C: Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996;35:244-7.
44. Sambrook P, Birmingham J, Kelly P, et al: Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993;328:1747-52.